MultiCTR Randomized Double-Blind Double-Dummy Dose-Ranging Study to Evaluate Clinical Efficacy/Safety of 2 Doses of DR 6MP for Targeted Ileal Delivery vs Purinethol in Non-Steroid Dependent Patients w/Moderately Active Crohn's Disease.

Trial Profile

MultiCTR Randomized Double-Blind Double-Dummy Dose-Ranging Study to Evaluate Clinical Efficacy/Safety of 2 Doses of DR 6MP for Targeted Ileal Delivery vs Purinethol in Non-Steroid Dependent Patients w/Moderately Active Crohn's Disease.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 14 Mar 2013

At a glance

  • Drugs Mercaptopurine (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2011 Planned end date changed from 1 Dec 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 08 Nov 2010 Actual initiation date (November 2010) added as reported by ClinicalTrials.gov.
    • 08 Nov 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top